The latest price and market trends of Trientine capsules in 2025

Trientine capsules have been officially approved for marketing in mainland China and are an important drug for the treatment of Wilson's disease (a disease with abnormal copper metabolism). It is not yet included in the national medical insurance catalog, so patients must purchase it at their own expense. Due to the relatively recent launch, the specific selling price in tertiary hospitals or specialty pharmacies in various regions has not yet been unified. It is recommended that patients contact local hospital pharmacies or specialty drug outpatient clinics to obtain price information and make an appointment to purchase.

In foreign markets, many types of trientine capsules (specification: 200 mg The price may vary due to brand, supply chain, taxes, and exchange rate fluctuations. Therefore, patients purchasing drugs through regular overseas medical channels need to confirm the price and import process in advance.

The global Wilson's disease drug market is growing significantly. According to market research reports, the global copper chelator market size is expected to be approximately US$590 million in 2025, and will grow significantly by the 2030s. As one of the important ingredients, trientine's API supply is mainly concentrated in countries such as India and China. API prices range from about 8,000–12,000 US dollars per kilogram, reflecting the high cost pressure at the raw material level of the drug.

Since the country has not yet entered the medical insurance system, it is recommended that patients in need give priority to consulting hospitals or specialty drug centers with direct drug supply qualifications for the exact price and drug purchase process. If you consider overseas purchasing, be sure to choose a legal cross-border medical service platform or contact a regular pharmacy through a doctor's guidance to avoid the risks caused by illegal purchasing. At the same time, liver and kidney function should be evaluated before medication, and copper metabolism indicators and blood routine should be reviewed regularly during treatment to ensure efficacy and medication safety.

Reference materials:https://www.drugs.com/